Methicillin-Resistant Staphylococcus aureus Epidemiology<\/p>\n
DRG Epidemiology’s coverage of methicillin-resistant staphylococcus aureus comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the incidence of methicillin-resistant staphylococcus aureus for each country, as well as annualized case counts projected to the national population.<\/p>\n
DRG Epidemiology’s methicillin-resistant staphylococcus aureus forecast will answer the following questions:<\/p>\n
How will changes in the levels of exposure to known risk or protective factors affect the number of methicillin-resistant staphylococcus aureus events per year?<\/p>\n
Of all people diagnosed with methicillin-resistant staphylococcus aureus, how many in each country across the major mature pharmaceutical markets are drug-treated?<\/p>\n
How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of methicillin-resistant staphylococcus aureus over the forecast period?<\/p>\n
All forecast data are available on the DRG Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.<\/p>\n
DRG Epidemiology provides at least ten years of forecast data for the following methicillin-resistant staphylococcus aureus patient populations:<\/p>\n
Diagnosed MRSA Events by Treatment<\/p>\n
Methicillin-Resistant Staphylococcus aureus Diagnosed MRSA Events<\/p>\n
Methicillin-Resistant Staphylococcus aureus Diagnosed MRSA Events – BSI<\/p>\n
Methicillin-Resistant Staphylococcus aureus Diagnosed MRSA Events – cIAI<\/p>\n
Methicillin-Resistant Staphylococcus aureus Diagnosed MRSA Events – cSSSI<\/p>\n
Methicillin-Resistant Staphylococcus aureus Diagnosed MRSA Events – HAP<\/p>\n
Methicillin-Resistant Staphylococcus aureus Diagnosed MRSA Events – HCAP<\/p>\n
Methicillin-Resistant Staphylococcus aureus Diagnosed MRSA Events – Nosocomial Pneumonia<\/p>\n
Methicillin-Resistant Staphylococcus aureus Diagnosed MRSA Events – SSI<\/p>\n
\u2026 and more (details available on request).<\/p>\n
Note: coverage may vary by country and region.<\/p>\n","protected":false},"template":"","class_list":["post-252957","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-methicillin-resistant-staphylococcus-aureus-infections","biopharma-product-epidemiology","biopharma-geography-europe","biopharma-geography-us","biopharma-date-890"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/252957","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/252957\/revisions"}],"predecessor-version":[{"id":285498,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/252957\/revisions\/285498"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=252957"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}